DrugInfoSys

Saruplase

Drug #2036

Saruplase is a thrombolytic drug.It is a urokinase type plasminogen activator with a single chain structure prepared via recombinant DNA technology and is converted to urokinase.

Primary Characteristics

It belongs to prourokinase.

Molecular Weight: 46343.1 · Non-proprietary name: Saruplase.

Molecular structure of Saruplase

Pharmacokinetics

None recorded.

Advertisement

Indications

Saruplase is primarily indicated in conditions like Myocardial infarction.

Contraindications

Saruplase is contraindicated in conditions like Hypersensitivity.

Dosage

None recorded.

Drug Interactions

1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Saruplase in overdosage may give rise to further complications which include Bleeding , Cerebral hemorrhage, Thromboembolic stroke.

Warnings / Precautions

Available Brands

None recorded.

Drug Classification

  1. 1.12.5Anti-thrombotic drugs and myocardial infarction